Free
AGORACOM NEWS FLASH

BREAKING NEWS!!!

TetraBio-Pharma Receives Approval to List on the TSX Venture Exchange

Tbp large new

  • Bernard Fortier, CEO of Tetra Bio-Pharma Inc. stated “... We look forward to aggressively executing our business plan as we build the leading bio-pharmaceutical organization focused on developing medicinal cannabis as pharmaceutical drugs.”

Hub On AGORACOM/ Corporate Profile / Read Release

Message: Grand hopes

As you said there are many unanswered quesions ?. Again one of the key questios that bring answer to some other puzzles is why they got rid off all the booking and computer stuff related to patents.

Mardee will have  big problem if there is no solid answer to destroying these documents. We have at least few ongoing royalty cases that we should know. We need to see article of corporation and its bylaw. How this possible all of members of the board unanimously resigned in the same day !  and at the same day filed for Chapter 7.

There are so many unanswered questions. Most of the Shareholder that i know or contacted me remain in  very depressed  and shocky mood as they lost their entire investment.

How you accept this bankruptcy when they write in their latest reoport such a optimistic forward looking statement !

From Latest 10-K

Concentration of Credit Risk and Sources of Supply

 

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and trade receivables. The Company maintains cash and cash equivalent accounts with Federal Deposit Insurance Corporation (“FDIC”) insured financial institutions. Certain of the Company’s accounts are each insured up to $250,000 by the FDIC. The Company had exposure in excess of FDIC insured limits of $17,269 at December 31, 2016. The Company has not experienced any losses in such accounts. The Company does not believe that it is subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. The Company performs periodic evaluations of the relative credit standing of these financial institutions. The Company has not experienced any significant losses on its cash equivalents.

 

Share
New Message
Please login to post a reply